Medtronic (MDT) Cash from Investing Activities Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -253.01% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -11.91% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -41.67% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -6.88% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -472.46% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -16.93% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -111.03% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -40.94% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | -2.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 23, 2026 | -41.67% |
| Oct 24, 2025 | 25.08% |
| Jul 25, 2025 | 23.16% |
| Apr 25, 2025 | -56.16% |
| Jan 24, 2025 | -24.48% |
| Oct 25, 2024 | 21.35% |
| Jul 26, 2024 | 30.87% |
| Apr 26, 2024 | -33.19% |
| Jan 26, 2024 | 36.59% |
| Oct 27, 2023 | 40.57% |
| Jul 28, 2023 | -310.90% |
| Apr 28, 2023 | -48.90% |
| Jan 27, 2023 | 45.78% |
| Oct 28, 2022 | 1.96% |
| Jul 29, 2022 | -42.22% |
| Apr 29, 2022 | 35.94% |
| Jan 28, 2022 | 24.34% |
| Oct 29, 2021 | -98.82% |
| Jul 30, 2021 | -47.66% |
| Apr 30, 2021 | 158.57% |
| Jan 29, 2021 | -94.31% |
| Oct 30, 2020 | -32.65% |
| Jul 31, 2020 | -54.15% |
| Apr 24, 2020 | 49.51% |
| Jan 24, 2020 | -24.11% |
| Oct 25, 2019 | -155.39% |
| Jul 26, 2019 | -24.72% |
| Apr 26, 2019 | -28.38% |
| Jan 25, 2019 | -58.37% |
| Oct 26, 2018 | 28.29% |
| Jul 27, 2018 | 38.42% |
| Apr 27, 2018 | 26.15% |
| Jan 26, 2018 | 18.18% |
| Oct 27, 2017 | 93.70% |
| Jul 28, 2017 | 151.11% |